Cambridge Healthtech Institute’s 9th Annual
Intensified and Continuous Processing
Optimising Process Intensification, Monitoring, and Control
11-12 March 2026
Intensified and continuous bioprocessing are redefining biologics manufacturing by driving greater productivity, cost-efficiency, and sustainability. CHI’s 9th Annual Intensified and Continuous Processing conference will highlight advances in developing, integrating, and implementing semi- and fully-continuous workflows across upstream and downstream processes for clinical and commercial production. Sessions will explore case studies and innovations in PAT, advanced modelling and control, digital twins, viral safety, cost analysis, and scaling strategies within global regulatory frameworks. Additional discussions will address sustainable biomanufacturing, material use, and end-of-product lifecycle considerations to support next-generation production platforms.
Coverage will include, but is not limited to:
- End-to-End Continuous Bioprocessing at GMP Scale – perfusion, hybrid/fully continuous workflows, and lab-to-pilot scale integration
- Advanced Analytics & Modelling – leveraging PAT, predictive control, and soft sensors to optimise processes
- Upstream & Downstream Intensification – N-1 perfusion, viral clearance in continuous settings, and strategies for ADCs and cell/gene therapies
- Simplification, Standardisation & Modularisation – enabling broader industry adoption of continuous processes
- Risk Assessment & Regulatory Considerations – navigating filings and developing robust control strategies for continuous workflows
- Business & Economic Drivers – building cases for adoption, facility design, and cost-benefit analysis of intensification strategies
- AI, Smart Manufacturing & Digitalisation – integrating AI, digital twins, and Bioprocessing 4.0 for advanced process control
- Continuous Processing in Microbial Systems – economic evaluation, case studies, and transitioning from fed-batch approaches
- Sustainable Biomanufacturing – environmentally friendly strategies, meeting Scope 3 emissions, and metrics for greener production
- Next-Generation CMC Approaches – simulation, performance prediction, and aligning process intensification with sustainability goals
The deadline for priority consideration is Friday 12 September.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: